Colchicine for Acute Gout

[...]the price increased 50-fold from about $0.10 to $5.00 per pill.1 This Cochrane review updates a 2006 meta-analysis of a single study of 43 people. The high-dose regimens in the two studies-which included a 1- to 1.2-mg loading dose, followed by either 0.6 mg every hour for six hours or 0.5 mg e...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American family physician 2015-06, Vol.91 (11), p.759-760
Hauptverfasser: Hitzeman, Nathan, MD, Stephens, Rebecca, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[...]the price increased 50-fold from about $0.10 to $5.00 per pill.1 This Cochrane review updates a 2006 meta-analysis of a single study of 43 people. The high-dose regimens in the two studies-which included a 1- to 1.2-mg loading dose, followed by either 0.6 mg every hour for six hours or 0.5 mg every two hours until therapeutic response or intolerance (i.e., nausea, vomiting, or diarrhea)-caused significantly more adverse effects (number needed to treat to harm = 2). There is a 1% risk of reversible axonal neuromyopathy in patients taking colchicine; colchicine can cause rhabdomyolysis when used with statins or clarithromycin (Biaxin); and colchicine has multiple drug-drug interactions with cytochrome P3A4 inhibitors, including certain antiviral agents, antifungal agents, calcium channel blockers, and grapefruit.3,4 Comparative studies among the different treatments for acute gout and for flare-up prophylaxis are needed.
ISSN:0002-838X
1532-0650